Saturday, October 24, 2026
Biotech

New Bill Aims to Speed Up Rare Disease Drugs

Lawmakers push a new plan to make rare disease trials faster and cheaper for patients.

Millions of people live with rare illnesses. Most wait years for medicines that could save their lives.

Now, lawmakers from both parties want to fix this delay. They introduced a bill to make clinical trials run faster. The plan cuts the high costs of drug testing. It also helps patients join tests from home.

Drug makers avoid rare disease research because trials cost too much. This new rule changes the math. It clears the path for smaller biotech firms to test new cures with fewer hurdles.

Faster trials mean life-saving treatments reach pharmacies sooner. Families waiting for hope can look forward to faster progress.

Source: CNBC

#Biotech#Healthcare#Congress#Clinical Trials#Medicine

More from Biotech